Intercept Pharmaceuticals

We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases, utilizing our proprietary bile acid chemistry. Our product candidates have the potential to treat orphan and more prevalent liver diseases for which there currently are limited therapeutic solutions. Offices in New York, San Diego and London.
Type
Public
HQ
New York, US
Founded
2002
Employees
405 (est)

Key People at Intercept Pharmaceuticals

James Mervis

James Mervis

Chairman
Barbara Duncan

Barbara Duncan

CFO
Luciano Adorini

Luciano Adorini

Chief Scientific Officer
Daniel Regan

Daniel Regan

Chief Commercial Officer
Mark Pruzanski

Mark Pruzanski

Founder ,CEO & Board Member

Intercept Pharmaceuticals Locations

New York, US

Intercept Pharmaceuticals Metrics

Intercept Pharmaceuticals Summary

Founding Date

2002

Market capitalization

$2.47 B

Closing share price

$100

Intercept Pharmaceuticals Market Value History

Intercept Pharmaceuticals News

Intercept Pharmaceuticals Company Life

You may also be interested in